Suppr超能文献

血管活性肠肽对人结肠癌细胞系中3',5'-单磷酸腺苷、鸟氨酸脱羧酶及细胞生长的影响

Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.

作者信息

Yu D, Seitz P K, Selvanayagam P, Rajaraman S, Townsend C M, Cooper C W

机构信息

Department of Pharmacology, University of Texas Medical Branch, Galveston 77550.

出版信息

Endocrinology. 1992 Sep;131(3):1188-94. doi: 10.1210/endo.131.3.1324153.

Abstract

Vasoactive intestinal peptide (VIP) is a widely distributed neuropeptide that has been considered a potential regulator of cell growth and differentiation in various tissues, including the gut. To examine this idea, we used a human colon carcinoma cell line (LoVo) as a model system and measured ornithine decarboxylase (ODC), because this is the rate-limiting enzyme for the formation of polyamines, which are thought to be key factors in regulating cell growth. LoVo cells, grown to about 80% confluence in F-12 medium containing 10% fetal bovine serum, were preincubated for 5 h in low serum medium (1% fetal bovine serum in F-12), and ODC activity was determined by measuring 14CO2 liberated from 14C-labeled ornithine. VIP caused a dose-related biphasic change in ODC, with activity increased at 10 pM, maximal (5-fold increase) at 10 nM, and decreased toward basal at 100 nM to 1 microM. Incubation of cells for 6 days with VIP in low serum medium showed similar changes in cell numbers, with growth being increased by doses in the 1 pM to 100 nM range and decreased at higher doses (greater than or equal to 100 nM). Exposure of cells to 5 mM alpha-difluoromethylornithine blocked both the VIP-induced increase in cell number and the VIP-induced increase in ODC activity. Increased ODC mRNA was detected after 2 h of exposure to VIP, a time at which ODC activity peaked after treatment, and the increase in ODC mRNA caused by VIP was dose-dependent. In related experiments LoVo cells were found to have high affinity VIP receptors (Kd = 0.4 nM), as assessed by examination of [125I]VIP binding in the presence of varying concentrations of unlabeled VIP. Studies of intracellular cAMP revealed a dose-related increase in cAMP in response to VIP (ED50 = 11 pM), and the adenylate cyclase activator forskolin increased both ODC activity and ODC mRNA. The findings support the idea that LoVo cells have VIP receptors linked to cAMP which can stimulate cell growth at least in part by increasing ODC synthesis and activity, thereby altering the production of polyamines. The decreased growth and ODC activity observed with high doses of VIP may involve a second messenger other than cAMP.

摘要

血管活性肠肽(VIP)是一种广泛分布的神经肽,被认为是包括肠道在内的各种组织中细胞生长和分化的潜在调节因子。为了验证这一观点,我们使用人结肠癌细胞系(LoVo)作为模型系统,并检测鸟氨酸脱羧酶(ODC),因为它是多胺形成的限速酶,而多胺被认为是调节细胞生长的关键因素。在含有10%胎牛血清的F-12培养基中生长至约80%汇合的LoVo细胞,在低血清培养基(F-12中含1%胎牛血清)中预孵育5小时,然后通过测量从14C标记的鸟氨酸释放的14CO2来测定ODC活性。VIP引起ODC呈剂量相关的双相变化,在10 pM时活性增加,在10 nM时达到最大值(增加5倍),在100 nM至1 μM时降至基础水平。在低血清培养基中用VIP孵育细胞6天,细胞数量呈现类似变化,在1 pM至100 nM范围内的剂量可促进生长,而在更高剂量(大于或等于100 nM)时生长减少。用5 mMα-二氟甲基鸟氨酸处理细胞可阻断VIP诱导的细胞数量增加和ODC活性增加。暴露于VIP 2小时后检测到ODC mRNA增加,此时处理后ODC活性达到峰值,且VIP引起的ODC mRNA增加呈剂量依赖性。在相关实验中,通过在不同浓度未标记VIP存在下检测[125I]VIP结合发现,LoVo细胞具有高亲和力VIP受体(Kd = 0.4 nM)。细胞内cAMP研究显示,对VIP的反应中cAMP呈剂量相关增加(ED50 = 11 pM),腺苷酸环化酶激活剂福斯可林可增加ODC活性和ODC mRNA。这些发现支持以下观点:LoVo细胞具有与cAMP相关的VIP受体,其可至少部分通过增加ODC合成和活性来刺激细胞生长,从而改变多胺的产生。高剂量VIP导致的生长和ODC活性降低可能涉及cAMP以外的第二信使。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验